Interested in learning more about Hyfe? Read about all of our news, announcements and insights here!
Imagine a World In Which Monitoring Cough Frequency can Predict and Prevent COPD Exacerbations
Cough is prevalent across diseases yet its tracking has been elusive, stalling scientific advancements. Hyfe's tech is changing this - we're now able to analyze objective cough data & predict risk.
Hyfe AI and ActiGraph Partner to Revolutionize Clinical Trials with AI-Powered Cough Detection
Hyfe's technology integrated into ActiGraph’s new FDA-cleared LEAP wearable device that will advance the use of remote patient monitoring in chronic cough clinical research.
Hyfe AI Announces New Remote Cough Monitoring Integration, Aiding to Reduce Patient Hospitalization and Improve Virtual Care
Studies show remote patient monitoring technology better predicts cough exacerbations to ultimately improve quality of life and reduce healthcare costs for patients with chronic cough.
Hyfe Announces Plans to Launch Digital Therapeutic for Chronic Coughers
Hyfe is expanding into chronic cough treatment with the world's first digital therapeutic for cough, using a proprietary model that combines real time cough frequency with cough suppression therapy.
Hyfe is Listed on CB Insights List of the Most Promising Digital Health Companies
150 winners selected out of 13,000 private companies; Hyfe recognized for contributions in screening, monitoring and diagnostics technologies
Hyfe Joins Forces with Merck to Deploy AI Cough-detection Technology
Hyfe has entered into an agreement with Merck, to integrate its artificial intelligence-powered (AI) cough tracker technology into Merck’s consumer disease educational efforts.
Press Release: Hyfe Deploys Artificial Intelligence-Powered Technology to Monitor, Screen and Diagnose Respiratory Illnesses
Leader in acoustic epidemiology empowers health care providers, researchers, pharmaceutical companies, and patients with cough detection and classification platform
Scientist use Hyfe to to track cough in Long Covid
Scientists use Hyfe to confirm that continuous cough monitoring for Long COVID was more sensitive in evaluating cough variability and response to treatment compared to patient reported outcomes.
Dr. Peter Small, Hyfe, Inc. Chief Medical Officer has Addressed the G20 meeting in Indonesia on the critical impact of digital innovation in combating Tuberculosis
Dr. Peter Small, Hyfe Chief Medical Officer has delivered deliver an intervention to the G20 Meeting in Yogyakarta, Indonesia, on the role of digital innovation in addressing public health crises.
Respiratory monitoring medtech firm appoints global expert as Chief Medical Officer
AI Medtech company Hyfe has announced the appointment of world-renowned Seattle-based physician and scientist Dr. Peter Small to the role of Chief Medical Officer.
Hyfe in the wall street journal: Coughs say a lot about your health, if your smartphone is listening
With apps and artificial intelligence, researchers want to use the cough to better diagnose asthma, Covid-19 and other respiratory illnesses